Cargando…

Assessment of a Serum Microrna Risk Score for Colorectal Cancer among Participants of Screening Colonoscopy at Various Stages of Colorectal Carcinogenesis

We recently derived and validated a serum-based microRNA risk score (miR-score) which predicted colorectal cancer (CRC) occurrence with very high accuracy within 14 years of follow-up in a large population-based cohort. Here, we aimed to assess and compare the distribution of the miR-score among par...

Descripción completa

Detalles Bibliográficos
Autores principales:	Raut, Janhavi R., Bhardwaj, Megha, Niedermaier, Tobias, Miah, Kaya, Schrotz-King, Petra, Brenner, Hermann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367813/ https://www.ncbi.nlm.nih.gov/pubmed/35954306 http://dx.doi.org/10.3390/cells11152462

Ejemplares similares

A microRNA panel compared to environmental and polygenic scores for colorectal cancer risk prediction
por: Raut, Janhavi R., et al.
Publicado: (2021)

Comparison of Proteomic Technologies for Blood-Based Detection of Colorectal Cancer
por: Bhardwaj, Megha, et al.
Publicado: (2021)

Whole-blood DNA Methylation Markers for Risk Stratification in Colorectal Cancer Screening: A Systematic Review
por: Raut, Janhavi R., et al.
Publicado: (2019)

Fecal DNA methylation markers for detecting stages of colorectal cancer and its precursors: a systematic review
por: Raut, Janhavi R., et al.
Publicado: (2020)

Fecal microRNAs, Fecal microRNA Panels, or Combinations of Fecal microRNAs with Fecal Hemoglobin for Early Detection of Colorectal Cancer and Its Precursors: A Systematic Review
por: Zhao, Zitong, et al.
Publicado: (2021)

Fecal Immunochemical Tests Detect Screening Participants with Multiple Advanced Adenomas Better than T1 Colorectal Cancers
por: Gies, Anton, et al.
Publicado: (2021)

Metabolomics Biomarkers for Detection of Colorectal Neoplasms: A Systematic Review
por: Erben, Vanessa, et al.
Publicado: (2018)

Correlation of Repeat Measurements of 27 Candidate Protein Markers for Colorectal Cancer Screening Taken Three Years and Multiple Freeze–Thaw Cycles Apart
por: Bhardwaj, Megha, et al.
Publicado: (2022)

Comparing Metabolomics Profiles in Various Types of Liquid Biopsies among Screening Participants with and without Advanced Colorectal Neoplasms
por: Erben, Vanessa, et al.
Publicado: (2021)

Cell Line Secretome and Tumor Tissue Proteome Markers for Early Detection of Colorectal Cancer: A Systematic Review
por: Bhardwaj, Megha, et al.
Publicado: (2017)

A serum microRNA signature for enhanced selection of people for lung cancer screening
por: Yu, Haixin, et al.
Publicado: (2022)

Blood-Based Protein Signatures for Early Detection of Colorectal Cancer: A Systematic Review
por: Bhardwaj, Megha, et al.
Publicado: (2017)

Flexible sigmoidoscopy in colorectal cancer screening: implications of different colonoscopy referral strategies
por: Niedermaier, Tobias, et al.
Publicado: (2018)

Multiplex screening of 275 plasma protein biomarkers to identify a signature for early detection of colorectal cancer
por: Bhardwaj, Megha, et al.
Publicado: (2019)

Effects of Alternative Offers of Screening Sigmoidoscopy and Colonoscopy on Utilization and Yield of Endoscopic Screening for Colorectal Neoplasms: Protocol of the DARIO Randomized Trial
por: Schrotz-King, Petra, et al.
Publicado: (2020)

Prevalence of Colorectal Neoplasia 10 or More Years After a Negative Screening Colonoscopy in 120 000 Repeated Screening Colonoscopies
por: Heisser, Thomas, et al.
Publicado: (2023)

Consistent Major Differences in Sex- and Age-Specific Diagnostic Performance among Nine Faecal Immunochemical Tests Used for Colorectal Cancer Screening
por: Gies, Anton, et al.
Publicado: (2021)

Evaluation and Validation of Plasma Proteins Using Two Different Protein Detection Methods for Early Detection of Colorectal Cancer
por: Bhardwaj, Megha, et al.
Publicado: (2019)

Direct comparison of ten quantitative fecal immunochemical tests for hemoglobin stability in colorectal cancer screening
por: Gies, Anton, et al.
Publicado: (2018)

Combination of Different Fecal Immunochemical Tests in Colorectal Cancer Screening: Any Gain in Diagnostic Performance?
por: Gies, Anton, et al.
Publicado: (2019)

Fibroblast growth factor 21 as a circulating biomarker at various stages of colorectal carcinogenesis
por: Qian, Jing, et al.
Publicado: (2018)

Vitamin D Status, Cdx2 Genotype, and Colorectal Cancer Survival: Population-Based Patient Cohort
por: Gwenzi, Tafirenyika, et al.
Publicado: (2023)

Potential of Inflammatory Protein Signatures for Enhanced Selection of People for Lung Cancer Screening
por: Bhardwaj, Megha, et al.
Publicado: (2022)

Risk Factors of Inadequate Bowel Preparation for Screening Colonoscopy
por: Amitay, Efrat L., et al.
Publicado: (2021)

Stage-Specific Sensitivity of Fecal Immunochemical Tests for Detecting Colorectal Cancer: Systematic Review and Meta-Analysis
por: Niedermaier, Tobias, et al.
Publicado: (2020)

Association of Overweight, Obesity, and Recent Weight Loss With Colorectal Cancer Risk
por: Mandic, Marko, et al.
Publicado: (2023)

Fecal Immunochemical Tests Combined With Other Stool Tests for Colorectal Cancer and Advanced Adenoma Detection: A Systematic Review
por: Niedermaier, Tobias, et al.
Publicado: (2016)

Prognostic Value of Post-Operative C-Reactive Protein-Based Inflammatory Biomarkers in Colorectal Cancer Patients: Systematic Review and Meta-Analysis
por: Gwenzi, Tafirenyika, et al.
Publicado: (2023)

Colorectal Cancer Risk by Genetic Variants in Populations With and Without Colonoscopy History
por: Guo, Feng, et al.
Publicado: (2021)

Impact of Reducing Intake of Red and Processed Meat on Colorectal Cancer Incidence in Germany 2020 to 2050—A Simulation Study
por: Niedermaier, Tobias, et al.
Publicado: (2023)

Is the association of overweight and obesity with colorectal cancer underestimated? An umbrella review of systematic reviews and meta-analyses
por: Mandic, Marko, et al.
Publicado: (2023)

The underestimated impact of excess body weight on colorectal cancer risk: Evidence from the UK Biobank cohort
por: Safizadeh, Fatemeh, et al.
Publicado: (2023)

Colorectal Carcinogenesis: MSI-H Versus MSI-L
por: Pawlik, Timothy M., et al.
Publicado: (2004)

A single measurement of fecal hemoglobin concentration outperforms polygenic risk score in colorectal cancer risk assessment
por: Niedermaier, Tobias, et al.
Publicado: (2023)

Reproductive Factors and Colorectal Cancer Risk: A Population-Based Case-Control Study
por: Amitay, Efrat L, et al.
Publicado: (2022)

Colonoscopy for Colorectal Cancer Screening
por: Young, Patrick E., et al.
Publicado: (2013)

Evaluation of different stool extraction methods for metabolomics measurements in human faecal samples
por: Erben, Vanessa, et al.
Publicado: (2021)

Virtual colonoscopy in stenosing colorectal cancer
por: Coccetta, Marco, et al.
Publicado: (2009)

Detection of colorectal lesions during colonoscopy
por: Ikematsu, Hiroaki, et al.
Publicado: (2021)

Colorectal cancer after negative colonoscopy in fecal immunochemical test-positive participants from a colorectal cancer screening program
por: Rivero-Sánchez, Liseth, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_a12fug55bvucjg3qffkvjfgd55